Literature DB >> 15681500

Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong.

C C Leung1, W W Yew, C M Tam, C K Chan, K C Chang, W S Law, S N Lee, M Y Wong, K F Au.   

Abstract

BACKGROUND: In Hong Kong there has been nearly universal neonatal BCG vaccination coverage since 1980.
METHOD: 21 113 schoolchildren aged 6-9 years were skin tested with one unit of tuberculin (PPD RT-23) using the intradermal technique during a routine BCG revaccination programme. Information on sex, date of birth, date of tuberculin testing, and tuberculin reaction size at 72 hours was retrieved. The annual risk of tuberculous infection (ARTI) was estimated by three different approaches.
RESULTS: Significantly higher tuberculin positive rates were found in girls and with increasing age at all commonly used cut-off points (5, 10, and 15 mm). Using a cut-off point of > or =10 mm and the formula 1- (1 - tuberculin positive rate)(1/age), the ARTI was estimated to be 1.93% (95% CI 1.84 to 2.03) for girls and 1.41% (95% CI 1.33 to 1.50) for boys. Using the differences in the tuberculin positive rate between the 6-7 year and 8-9 year age groups, the ARTI became 1.90% (95% CI 1.09 to 2.70) and 1.84% (95% CI 1.15 to 2.54) for girls and boys, respectively. When the prevalence of infection was estimated by locating a secondary peak of the tuberculin reaction distribution curve at 15 mm and assuming a symmetrical distribution of reaction sizes among those infected around this peak, the corresponding ARTI was much lower at 0.52% (95% CI 0.46 to 0.59) and 0.43% (95% CI 0.37 to 0.49) for girls and boys, similar to that estimated indirectly from the prevalence of disease.
CONCLUSION: The ARTI as estimated by conventional methods was unexpectedly high among BCG vaccinated children and did not agree with that anticipated from the annual incidence of active disease. Further studies are needed to address the discrepancies, including the possible interaction between BCG and other environmental stimuli.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681500      PMCID: PMC1747293          DOI: 10.1136/thx.2003.017970

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  Reactivity and assay restriction profiles of monoclonal and polyclonal antibodies to acid phosphatases: a preliminary study.

Authors:  H Bull; M Choy; I Manyonda; C A Brown; E E Waldron; S D Holmes; J C Booth; P N Nelson
Journal:  Immunol Lett       Date:  1999-12-01       Impact factor: 3.685

2.  Magnitude of recall bias in the estimation of immunization coverage and its determinants.

Authors:  R Ramakrishnan; T V Rao; L Sundaramoorthy; V Joshua
Journal:  Indian Pediatr       Date:  1999-09       Impact factor: 1.411

3.  BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size.

Authors:  S Floyd; J M Ponnighaus; L Bliss; D K Warndorff; A Kasunga; P Mogha; P E Fine
Journal:  Int J Tuberc Lung Dis       Date:  2000-12       Impact factor: 2.373

4.  Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren.

Authors:  C B Chee; C H Soh; I C Boudville; S S Chor; Y T Wang
Journal:  Am J Respir Crit Care Med       Date:  2001-09-15       Impact factor: 21.405

5.  Tuberculosis infection in an Aboriginal (First Nations) population of Canada.

Authors:  C Smeja; P Brassard
Journal:  Int J Tuberc Lung Dis       Date:  2000-10       Impact factor: 2.373

6.  Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong.

Authors:  C C Leung; C M Tam; S L Chan; M Chan-Yeung; C K Chan; K C Chang
Journal:  Int J Tuberc Lung Dis       Date:  2001-08       Impact factor: 2.373

7.  Effect of BCG vaccine on tuberculin skin tests in 1-6-year-old children.

Authors:  A Bozaykut; I Ozahi Ipek; M Y Ozkars; L Pulat Seren; E Atay; Z Atay
Journal:  Acta Paediatr       Date:  2002       Impact factor: 2.299

8.  BCG coverage and the annual risk of tuberculosis infection over a 14-year period in the Philippines assessed from the Nationwide Prevalence Surveys.

Authors:  T E Tupasi; S Radhakrishna; M L Pascual; M I Quelapio; M L Villa; V M Co; J Sarol; N Mangubat; A C Reyes; A Sarmiento; M Solon; F Solon; L Burton; V S Lofranco; M P Rostrata; M J Mantala
Journal:  Int J Tuberc Lung Dis       Date:  2000-03       Impact factor: 2.373

9.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project.

Authors:  C Dye; S Scheele; P Dolin; V Pathania; M C Raviglione
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

10.  A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements.

Authors:  L Wang; M O Turner; R K Elwood; M Schulzer; J M FitzGerald
Journal:  Thorax       Date:  2002-09       Impact factor: 9.139

View more
  4 in total

1.  Whole blood IFN-gamma assay for detecting TB in children.

Authors:  A J Radford; J S Rothel; G Sberna
Journal:  Thorax       Date:  2006-10       Impact factor: 9.139

2.  Evaluation of Treatment Indications, Tuberculin Skin Test, and Bacillus Calmette-Guerin Vaccination Scars in the Cases of Latent Tuberculosis Infection Treatment.

Authors:  Beyhan Çakar
Journal:  Turk Thorac J       Date:  2017-09-27

3.  Tuberculin Reactivity in School Age Children; Five-year Follow-up in Iran.

Authors:  Mitra Hemmati; Keyghobad Ghadiri; Mansour Rezaei
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

Review 4.  In silico analysis and experimental validation of Mycobacterium tuberculosis -specific proteins and peptides of Mycobacterium tuberculosis for immunological diagnosis and vaccine development.

Authors:  Abu Salim Mustafa
Journal:  Med Princ Pract       Date:  2013-08-31       Impact factor: 1.927

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.